Explore evidence

87.5 %Squamous cell carcinoma was the prevalent histologic type in 87.5% of cases.

Nigeriacancer du col de l'utéruspublished 2025BrachytherapyPubMeddocument of 8 observations

62.1 %Of those who had heard of cervical cancer, 62.1% were aware that it could be prevented.

Nigeriacancer du col de l'utéruspublished 2020The Pan African medical journalPubMeddocument of 5 observations

0.49 ORRelative to Phase-2, knowledge changes at Phase-4 for questions associated with the myth 'enemy poisons' were reversed, with an odds ratio of 0.49 (95% CI: 0.37–0.65).

Nigeriacancer du col de l'utéruspublished 2022BMC public healthPubMeddocument of 13 observations

94.4 %Support for cervical cancer screening was high at 94.4% among women and male partners in Makurdi, North-Central Nigeria.

Nigeriacancer du col de l'utéruspublished 2025Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 6 observations

HPV16, HPV18, HPV45, HPV51, and HPV52 were the predominant high-risk HPV genotypes detected in both single and multiple HPV infections in cervical cancer tissues from Maiduguri, Nigeria, during 2013–2015.

Nigeriacancer du col de l'utérusobserved 2013-2015published 2019The Pan African medical journalPubMeddocument of 4 observations

27 casesAmong 168 pregnant women in Otukpo metropolis, 27 (16.1%) have undergone recommended checkup for human papilloma virus/cervical cancer.

Nigeriacancer du col de l'utérus · human papilloma viruspublished 2024Ethiopian journal of health sciencesPubMeddocument of 7 observations

The mean knowledge score of cervical cancer in the intervention group increased from 0.0 ± 0.3 at baseline to 15.1 ± 3.7 post-intervention.

Nigeriacancer du col de l'utéruspublished 2022BMC women's healthPubMeddocument of 5 observations

7.2 %Post-intervention, risk factor knowledge improved to 7.2% in the control group.

Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 12 observations

7 %7% (3/43) of art entries included 'nurturers', representing self-regulation addressing stresses linked to having relatives with cervical cancer.

Nigeriacancer du col de l'utéruspublished 2026JMIR formative researchPubMeddocument of 7 observations

161 casesAmong 168 pregnant women in Otukpo metropolis, 161 (95.8%) demonstrated poor practices regarding HPV infection, cervical cancer and vaccination.

Nigeriacancer du col de l'utérus · human papilloma viruspublished 2024Ethiopian journal of health sciencesPubMeddocument of 7 observations

70 %The cervical cancer screening rate has not reached the WHO target of 70%.

Nigeriacancer du col de l'utéruspublished 2023BMC women's healthPubMeddocument of 7 observations

66.67 %The predominant EBRT regimen was 1.8 Gy × 25 fractions in 66.67% of patients.

Nigeriacancer du col de l'utéruspublished 2025BrachytherapyPubMeddocument of 8 observations

33.5 %33.5% of the respondents had encouraged their female partners to screen for cervical cancer.

Nigeriacancer du col de l'utérusobserved 2018published 2023PloS onePubMeddocument of 14 observations

20.8 %20.8% of the 231 women had basic information on the risk factors of cervical cancer.

Nigeriacancer du col de l'utéruspublished 2021Cancer treatment and research communicationsPubMeddocument of 11 observations

38 yearsOn average, women were first screened for cervical cancer at age 38 at Jos University Teaching Hospital in Nigeria.

Nigeriacancer du col de l'utéruspublished 2024Cancer causes & control : CCCPubMeddocument of 5 observations

9 per_10Over 9 of 10 women in a rural community in Enugu State, Nigeria, were willing to vaccinate their children against cervical cancer.

Nigeriacancer du col de l'utéruspublished 2026Rural and remote healthPubMeddocument of 8 observations

43 %43% of the respondents cited lack of a doctor's request as the most common reason for not having undergone cervical screening.

Nigeriacancer du col de l'utéruspublished 2024African health sciencesPubMeddocument of 5 observations

87.9 %Among 400 female students in tertiary institutions in Imo State, 350 (87.9%) have heard of cervical cancer.

Nigeriacancer du col de l'utéruspublished 2021Journal of community healthPubMeddocument of 9 observations

81 %A high percentage of the respondents, 350 (81.0%), had heard about cervical cancer screening.

Nigeriacancer du col de l'utéruspublished 2023Cancer treatment and research communicationsPubMeddocument of 5 observations

70.4 %70.4% of the female postgraduate students at the University of Ibadan disagreed that cervical cancer is a mild disease.

Nigeriacancer du col de l'utéruspublished 2024BMC women's healthPubMeddocument of 6 observations

48.9 %48.9% of respondents vaccinated their wards to prevent cervical cancer.

Nigeriacancer du col de l'utéruspublished 2024Reproductive healthPubMeddocument of 16 observations

14.6 %Only 14.6% of the female secondary school teachers in Enugu metropolis had taught their students about cervical cancer or HPV vaccines.

Nigeriacancer du col de l'utérusobserved 2017published 2021The Pan African medical journalPubMeddocument of 7 observations

7.5 %7.5% of the participants strongly agreed that they do not see the need for cervical screening.

Nigeriacancer du col de l'utéruspublished 2023BMC women's healthPubMeddocument of 7 observations

92.9 %A machine learning-based DNA methylation classifier achieved 92.9% sensitivity and 88.6% specificity in predicting cervical cancer risk.

Nigeriacancer du col de l'utéruspublished 2025International journal of cancerPubMeddocument of 3 observations

The mean attitude score of cervical cancer in the intervention group increased from 27.1 ± 0.8 at baseline to 36.5 ± 4.8 post-intervention.

Nigeriacancer du col de l'utéruspublished 2022BMC women's healthPubMeddocument of 5 observations